HERON THERAPEUTICS, INC. /DE/ Proceeds from Issuance of Private Placement
HERON THERAPEUTICS, INC. /DE/ (HRTX) reported Proceeds from Issuance of Private Placement of $29.75 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2024-11-12
- 2023-09-30: .
- 2022-09-30: .
- 2012-07-31: Proceeds from Issuance of Private Placement 1 month $50.50M; Proceeds from Issuance of Private Placement 1 month as first filed $53.60M.
- 2012-07-30: Proceeds from Issuance of Private Placement 1 month $53.60M.
| Period end | Proceeds from Issuance of Private Placement 1 month | Proceeds from Issuance of Private Placement 1 month as first filed | Proceeds from Issuance of Private Placement 2 month | Proceeds from Issuance of Private Placement 6 month | Proceeds from Issuance of Private Placement 9 month |
|---|---|---|---|---|---|
| 2023-09-30 | $29.75M 10-Q · filed 2024-11-12 | ||||
| 2022-09-30 | $75.16M 10-Q · filed 2023-11-14 | ||||
| 2012-07-31 | $50.50M 10-K · filed 2014-03-07 | $53.60M 10-Q · filed 2012-11-05 | |||
| 2012-07-30 | $53.60M 10-Q · filed 2012-08-09 | ||||
| 2011-07-31 | $3.70M 10-Q · filed 2012-11-05 | $24.00M 10-Q · filed 2012-11-05 | |||
| 2011-06-30 | $20.30M 10-Q · filed 2012-11-05 | $20.30M 10-Q · filed 2011-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |